{"id":148,"date":"2017-01-11T18:38:25","date_gmt":"2017-01-11T10:38:25","guid":{"rendered":"https:\/\/credevo.com\/articles\/\/?p=148"},"modified":"2021-09-20T18:35:25","modified_gmt":"2021-09-20T10:35:25","slug":"brazil-phase-ii-clinical-trial-in-allergic-rhinitis","status":"publish","type":"post","link":"https:\/\/credevo.com\/articles\/2017\/01\/11\/brazil-phase-ii-clinical-trial-in-allergic-rhinitis\/","title":{"rendered":"Brazil! Phase II Clinical Trial in Allergic Rhinitis"},"content":{"rendered":"\n

Investigators, from Brazil who were specialized in Allergy and Immunology segment, were invited to participate in feasibility of a new phase II clinical trial.<\/p>\n\n\n\n

\"Brazil-Phase-II-Clinical-Trial-in-Allergic-Rhinitis-Join-in\"<\/figure>\n\n\n\n

What’s was the trial about?<\/h2>\n\n\n\n

It’s a phase II – dose selection and confirmatory – clinical trial planned to be conducted in Brazil.<\/p>\n\n\n\n

What kind of patients were required for this clinical trial?<\/h2>\n\n\n\n

Patients suffering from perennial allergy were included in this clinical trial.  A physician diagnosed allergy or a convincing clinical history of allergy in upper or lower respiratory symptoms was considered as one of the primary criteria for inclusion in a clinical trial. Other details can be reviewed on Credevo<\/a>.<\/p>\n\n\n\n

What was this study aiming at?<\/h2>\n\n\n\n

The objective of this study is to determine the optimum dose of the drug under evaluation. A dose will be selected based on the efficacy and safety data of the Phase II study. This selected dose will be administered in a larger group of patients in a phase III study, which will also be conducted in Brazil.<\/p>\n\n\n\n

Who were managing this clinical trial?<\/h2>\n\n\n\n

This clinical trial was managed by a trial management team based in the United States. The management team contacted selected and interested investigators for detailed feasibility.<\/p>\n\n\n\n

Have some more questions or request a Feasibility Report, Contact us!<\/h2>\n\n\n\n

You’re most welcome to contact us<\/em> by filling in details in the below form. for any questions, you may have. Your queries will be responded to within 24-48 hours.<\/p>\n\n\n\n

\n\n\n\n

Contact Investigators From This Feasibility Assessment<\/h2>\n\n\n\n

Would you like to contact these investigators and assess feasibility with them for your clinical trial? or Do you need any support in conducting such clinical trials?<\/p>\n\n\n\n

Just provide your requirement details & email below. Don\u2019t worry, your email will not be published or shared.<\/p>\n\n\n